论文部分内容阅读
目的观察戊酸雌二醇配伍安宫黄体酮序贯治疗对药物流产不全的疗效。方法将药物流产不全的120例患者随机分成3组,各组40例,残留物平均直径≤1.5cm者分为A、B组,残留物平均直径>1.5cm且≤3.1cm者为C组,A组和C组采用戊酸雌二醇配伍安宫黄体酮序贯治疗,B组采用新生化冲剂治疗,比较3组的临床疗效。结果 A组止血率(100.0%)和有效率(92.5%)明显高于B组止血率(35%)和有效率(35%),A组有效率高于C组(57.7%),差异有统计学意义(P<0.01),A组与C组止血率差异无统计学意义(P>0.05)。结论戊酸雌二醇配伍安宫黄体酮序贯治疗药物流产不全的疗效肯定,残留物平均直径>1.5cm疗效降低。
Objective To observe the effect of consecutive administration of valerate valerate and medroxyprogesterone acetate on incomplete medical abortion. Methods A total of 120 patients with incomplete medical abortion were randomly divided into three groups, 40 cases in each group. The average residue diameter ≤1.5cm were divided into group A and group B. The average residue diameter> 1.5cm and ≤3.1cm were group C, Group A and C were treated with progesterone acetate valerate vasodilate sequential treatment, and group B was treated with neo-biochemical granules. The clinical efficacy was compared between the three groups. Results The hemostatic rate (100.0%) and effective rate (92.5%) in group A were significantly higher than those in group B (35%) and effective rate (35%). The effective rate in group A was higher than that in group C (57.7% Statistical significance (P <0.01), A group and C group bleeding rate difference was not statistically significant (P> 0.05). Conclusions estradiol valerate compatibility and progesterone progesterone sequential treatment of drug abortion incomplete efficacy of the residue, the average diameter of> 1.5cm curative effect decreased.